Category Archives: Cancer Research

Alternative Cancer Treatment, Cancer Research

Cancer Risks Are Linked to Cell Division

T Cells
Cell Division Linked To Cancer

Cancer is effected by numerous and complex risk factors, making concepts related to calculating its risk a frequent subject of debate. Adding to this debate is a recent study looking at randomly mutating cells, specifically how they play a predominant role in cancer development. What does this say about your cancer risk? Issels® wants to help you put this new information in perspective.

Cancer and car accidents: They have a lot in common…

  • Trip length
    Comparing getting cancer to getting into a car accident, the length of your trip – your lifespan – increases your risk. The longer you live, the more the odds increase of your body randomly mutating cells, making this a significant risk factor – attributable to two-thirds of your total cancer risk in fact.
  • Road conditions
    Just as rain or snow can increase your risk of an accident, so too can conditions in your body and in your environment increase your risk of cancer.
  • Mechanical issues
    Bad brakes or worn tires can be seen as a metaphor for genetic factors, such as inherited mutations.

Reading the accident report
Despite this research, it can’t be stressed enough no single factor causes cancer. Two-thirds of car accidents are not related solely to trip length, but to a combination of road conditions, mechanical issues, and the like. For each “accident,” the major contributing factor will vary.

Accident prevention
Due to the large combination of risk factors, there are many opportunities for prevention, including addressing radiator issues (smoking), regular maintenance (early diagnostics and detection), and more.

Cancer spinning out of control? Contact Issels® today.

Alternative Cancer Treatment, Cancer Research

The Hormone, called Irisin May Provide Breast Cancer Protection

Resistance Training
Using Exercise To Fight Breast Cancer

Exercising on a regular basis could help prevent breast cancer thanks to a hormone known as irisin. In the latest cancer research news, scientists at the University of New Mexico concluded that irisin, which is released from muscles after exercising, might provide protection from breast cancer. Its effects on the body might also improve the effectiveness of breast cancer treatment.

Effects of Irisin

Researchers targeted cancerous and non-cancerous breast cells with genetically engineered irisin. The results showed that irisin destroyed cancerous cells but left non-cancerous cells alone. After being exposed to the hormone, the number of cancerous cells decreased by 34 percent. Irisin also reduced cell migration by 51 percent, which could indicate that the hormone is able to slow down or prevent the spread of cancerous cells to other parts of the body.

Exercise and Cancer Prevention

These cancer research findings have shed some light on the reason why exercise plays an important role in cancer prevention and treatment. Other studies have established an association between working out and having a lower risk of cancer. The UNM study focused on how chemicals produced by the body during exercise, specifically irisin, might have an effect on breast cancer. In addition to destroying cancerous cells, irisin also stays in the body for long periods of time, which provides even greater protection against cancer. While additional studies still need to be done, researchers are hopeful that these findings will encourage exercise as a form of cancer prevention and treatment.

To learn about non-toxic cancer treatments, please contact Issels®. We offer immunotherapy and other forms of non-toxic treatment methods for many different types of cancer.

Cancer Research, News

Team Finds New Treatment for Acute Myeloid Leukaemia (AML)

Cancer Research
Cancer Research Finds New Treatment for Blood Cancer

Australian researchers have found that a drug called Imetelstat has the potential to fight and sometimes defeat blood cancer. Following the recent trials in Brisbane, the FDA has recently cleared the way for clinical trials in the United States.

How Does Imetelstat Kill Cancer Cells?

The medication works by manipulating a particular protein of the blood. Imetelstat effectively “turns off” a certain gene to prevent the formation of a protein called telomerase. Without that protein, the stem cells that become leukemia cells cannot be formed. Existing cancer cells begin to disappear.

The news is especially exciting because chemotherapy has its lowest success rates with acute myeloid leukemia, or AML.

Patients who have undergone unsuccessful chemotherapy for AML can potentially use Imetelstat to prolong life or possibly enter remission. For all AML patients, Imetelstat could be used as a follow-up treatment after chemotherapy to help prevent the cancer from returning.

What’s Next for Blood Cancer Medicine?

After the Australian team recently published their findings and made a presentation to the American Society of Hematology, interest in the treatment has further increased.

The FDA had previously been concerned by a possible connection between Imetelstat and liver problems, but that issue has been ruled out. With that hurdle cleared, optimism is building for the breakthrough drug to succeed in human trials and find approval for all patients with AML.

Many alternative treatments are currently available for patients with cancer resistant to standard therapies. Contact Issels® Integrative Immuno-Oncology for information about our innovative cancer treatments.

Alternative Cancer Treatment, Cancer Research

The World Health Organization Says Your Cancer is Not Due to Bad Luck!

Gene and Cell Therapy
Differentiating Between Genetic and Other Cancers

With a recent study and headlines worldwide trumpeting that cancer is caused by bad luck, the World Health Organization just rebutted this claim in this recently published press release:

“The International Agency for Research on Cancer (IARC), WHO’s specialized cancer agency, strongly disagrees with the conclusion of a scientific report on the causes of human cancer by Dr Cristian Tomasetti and Dr Bert Vogelstein, published in the journal “Science” on 2 January 2015 and widely reported in the mass media.

The study suggests that random mutations (or “bad luck”) are the major contributors to cancer overall, often more important than either hereditary or external environmental factors.

“We already knew that, for an individual to develop a certain cancer, there is an element of chance, yet this has little to say about the level of cancer risk in a population,” explains IARC Director Dr Christopher Wild. “Concluding that ‘bad luck’ is the major cause of cancer would be misleading and may detract from efforts to identify the causes of the disease and effectively prevent it.”

While at Issels we know that certain measures can help reduce your risk of cancer, such as wearing sunscreen and not smoking, the researches slammed by the WHO stated that roughly two-thirds of cancer types result from random DNA mutations instead of high-risk behavior or heredity. The press picked this up as cancer simply caused by your own “bad luck”.

Mutations vs. Genetics

The study that was mentioned by the WHO included 31 types of cancer, and results showed that 22 of them were associated with random DNA mutations. These included brain, pancreatic and ovarian cancer. The nine types that weren’t linked to these mutations included skin cancer, lung cancer and other cancers that are more strongly associated with risk behaviors, environmental factors and heredity.

Why Would WHO Slam This Report?

The World Health Organization states that “According to current knowledge, nearly half of all cancer cases worldwide can be prevented.”

We don’t believe, like the WHO, that cancer is your fault. Get the facts and information you need on non-toxic ways to treat cancer at Issels. We offer a wide range of safe, effective methods, including cancer immunotherapy treatment.

 

Cancer Research

Should You Abstain from Alcohol to Keep Cancer at Bay?

Abstaining From Alcohol
Abstaining From Alcohol

One of the most tragic aspects of the hundreds of thousands of cancer related deaths that occur each year is that such a large percentage of them could have been avoided. According to the World Health Organization (WHO), harmful alcohol use causes more than 351,000 cancer-related deaths every year. At Issels® Integrative Immuno-Oncology, we strive to reduce cancer deaths by using proven treatment methods. But we also want you to make informed decisions about lifestyle choices that may increase your risk of developing cancer.

Drink for a healthy heart?

Moderate drinking has been credited with lowering the risk of cardiovascular disease, heart failure, and stroke. What is important to note about this is that alcohol consumption causes much more disease and death than it prevents. That is according to Ronald Watson, Ph.D who is a world-renowned alcohol researcher and professor at the University of Arizona.

Moderate consumption and cancer

Most people realize that alcoholics are at high risk of liver cancer. But less talked about is that moderate drinkers are likely increasing their risk for colorectal, esophagus, mouth, throat, and breast cancer. Researchers believe alcohol not only lowers the immune system’s defense of cancer, but the body’s action of metabolizing alcohol can cause cancer. For many people, the high risks associated with alcohol consumption outweigh the potential benefits of moderate drinking.

To learn more about the non-toxic cancer treatments that we have been using for more than 60 years to successfully treat patients with all forms and stages of cancer, contact Issels® Integrative Immuno-Oncology. To stay updated on the latest cancer news and research, sign up for our free e-Newsletter.

Cancer Research

Will Your Low Fat Diet Help You Beat Breast Cancer?

Woman with Basket of Food
A Low Fat Diet May Help You Beat Breast Cancer.

A study by Dr. Rowan Chlebowski, a medical oncologist at Harbor-UCLA Medical Center’s Los Angeles Biomedical Research Institute, shows that some women diagnosed with breast cancer who maintain a low-fat diet may reduce their risk of early death.

Research for women in the early stages of breast cancer specific to estrogen receptor-negative (ER-negative) cancer showed positive results. For this group, Dr. Chlebowski’s study showed a reduced risk of death factor of 36 percent over a 15-year study for patients who maintained a diet of low-fat food for five years after being diagnosed.

For women diagnosed with both ER-negative and progesterone-receptor negative (PR-negative) cancer, the results were even higher. Following the same five year low-fat diet regimen after initial diagnosis, patients experienced a 56 percent reduction in risk of death due to any cause.

The study included over 2,400 women ranging in age from 48 to 79 in the early stages of breast cancer. Of the 2,400 women, approximately 1,600 were diagnosed with ER-positive cancer while the remaining 800 were diagnosed with ER-negative or both ER and PR-negative cancer.

During the study, low-fat diets for half of the women was a requirement. Unannounced checks were made throughout the study. The other group was not required to maintain a low-fat diet. The study showed a lower death rate in the low-fat diet research group.

The study is the first where a low-fat diet over an extended period for cancer patients has been researched.

For information about how integrative immuno-oncology works in the treatment of breast cancer, contact Issels®. Established in 1951, Issels® has made a name for itself internationally for its success in the long-term remission of advanced tumors.